Key result
A 12-month therapeutic lifestyle change program improved adherence to dietary goals from 53% to 86% and exercise from 44% to 66%, with improvements in anthropometrics and laboratory values.
Why the study?
Does a comprehensive therapeutic lifestyle change program improve health behaviors and cardiovascular risk factors in adults?
Observational (n=648)
Does a comprehensive therapeutic lifestyle change program improve health behaviors and cardiovascular risk factors in adults?
Answers are grounded in this paper and cite their sources.
A comprehensive 12-month therapeutic lifestyle change program significantly improved adherence to healthy behaviors and surrogate cardiovascular risk markers.
The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personalized TLC action plans addressed modifiable health behaviors for diet, exercise, stress management, and sleep. Participants attended a half-day interactive workshop and met face-to-face with certified health coaches four times over 6 months. Monthly telephonic coaching for 6 more months completed the intervention. Measured outcomes included adherence to behavioral prescriptions, anthropometrics, CVD-relevant laboratory tests, and for a subset of participants, carotid intima-media thickness (CIMT). Of 965 participants, 648 (67%) completed the program and were included in the analysis. Participants were of mean age 55.4 ± 12.5 years, 57% women, and racially diverse. Adherence to prescribed TLC was substantial: dietary behaviors at goal rose from 53% to 86%, exercise 44% to 66%, perceived stress 65% to 79%, and sleep quality 28% to 49%. For participants with abnormal anthropometrics at baseline, there were improvements in body mass index in 63%, waist circumference (men 71%, women 74%), systolic BP 69%, and diastolic BP 71%. For participants with abnormal laboratory values at baseline, there were improvements in total cholesterol in 74%, LDL-cholesterol 65%, triglycerides 86%, fasting glucose 72%, and insulin resistance 71%. Improvements were not driven by prescribed medications. CIMT improved or showed no change in 70% of those measured, associated with significant improvements in sleep quality and longer total sleep time. Longer trials incorporating controls and major adverse CVD events are warranted.
No takes yet. Share an insight, caveat, or question.
Eliasson et al. (2021) conducted an observational in Cardiovascular disease risk factors (n=648). Therapeutic lifestyle change (TLC) was evaluated on Adherence to behavioral prescriptions, anthropometrics, CVD-relevant laboratory tests, and carotid intima-media thickness (CIMT). A 12-month therapeutic lifestyle change program improved adherence to dietary goals from 53% to 86% and exercise from 44% to 66%, with improvements in anthropometrics and laboratory values.
Synapse has enriched 10 related papers. Consider them for comparative context: